Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) Stock Score, Valuation & Financial Research
Park Ha Biological Technology Co., Ltd. Ordinary Shares is in the Consumer Defensive sector and Household & Personal Products industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 25/100.
Quick answer for BYAH
Park Ha Biological Technology Co., Ltd. Ordinary Shares currently has a Wall Street Score of 25/100. The stored market price is $2.38. Its financial score is 25/100. Its valuation score is 0/100. The latest WSS change is +0.2 points. These figures are a research snapshot, not a buy or sell recommendation.
What Park Ha Biological Technology Co., Ltd. Ordinary Shares does
This enterprise functions as an investment holding company, with its core business centered on crafting and distributing skincare solutions. Operating under the "Park Ha" brand, these products are sold across the People's Republic of China. The company executes these activities through its affiliated subsidiaries, which manage both direct product sales and the provision of franchise services.
BYAH financial snapshot
- Wall Street Score:
- 25/100
- Current price:
- $2.38
- Market capitalization:
- $1.8M
- Revenue:
- $3.8M
- Net income:
- $-8.2M
- Free cash flow:
- $-3K
- Cash:
- $628K
- Total debt:
- $186K
- EPS:
- -92.00
- Financial score:
- 25/100
- Valuation score:
- 0/100
- Revenue score:
- 41/100
What stands out
- Reported year-over-year revenue growth is +0.5%.
- Free cash flow is $-3K, showing cash burn in the current stored period.
- The balance sheet shows $628K of cash versus $186K of total debt, leaving more cash than debt.
- The latest Wall Street Score change is +0.2 points: BYAH increased 0.2 points because overall fundamentals improved.
- The current research record carries a corporate distress warning, which should be reviewed alongside the score.
What the numbers mean
Its current valuation score is 0/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 25/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-09-09.
How to research BYAH
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.